14Jul
Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....
By:
Goodwin
Related
On July 25, 2019, Acting Gov. Sheila Oliver signed NJ A1094 (“the Law”) banning salary history req...
Read More >
COVID-19 has impacted nearly every aspect of American life right now, and there are myriad legal iss...
Read More >
In today’s edition of Daily Compliance News: • Corruption across EU leaves EU Home Affairs Commis...
Read More >
As we wrote in a previous On the Subject, the Ninth Circuit Court of Appeals had signaled that it mi...
Read More >
The abrupt halt to day-to-day operations over the last two weeks is forcing a series of unwelcome de...
Read More >
Unlicensed contractors in Georgia recently were dealt a blow by the state's Court of Appeals when th...
Read More >